Search research articles
Contact Us
Filters
Showing results (61-70 of 192) with videos related to
Page
of 20
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)
|
September 26, 2019
Study of <i>In Vitro</i> Synergistic Bactericidal Activity of Dual β-Lactam Antibiotics Against KPC-2-Producing <i>Klebsiella pneumoniae</i>
Wenxia Zhang, Yan Guo, Yang Yang, et al.
Antimicrobial Agents and Chemotherapy
|
February 16, 2011
High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum beta-lactamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China
Shudan Chen, Fupin Hu, Xiaogang Xu, et al.
The Journal of Antimicrobial Chemotherapy
|
August 13, 2018
Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae
Jiachun Su, Qinglan Guo, Ying Li, et al.
Plos One
|
April 18, 2013
Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and intestinal commensal Escherichia coli strains
Xiaohua Qin, Fupin Hu, Shi Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 14, 2018
A Case-Control Study: Clinical Characteristics of Nosocomial Bloodstream Infections Versus Non-bloodstream Infections of Acinetobacter spp
Su Xu, Ying Li, Xiaogang Xu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 14, 2025
Emergence of ceftazidime-avibactam resistance in clinical Klebsiella pneumoniae during therapy
Siquan Shen, Xiren Deng, Lu Guo, et al.
International Journal of Antimicrobial Agents
|
June 1, 2024
Dynamic evolution of ceftazidime-avibactam resistance from a single patient through the IncX3_NDM-5 plasmid transfer and bla<sub>KPC</sub> mutation
Chengkang Tang, Siquan Shen, Weiwei Yang, et al.
Frontiers in Microbiology
|
July 25, 2022
High Prevalence and Overexpression of Fosfomycin-Resistant Gene <i>fos</i>X in <i>Enterococcus faecium</i> From China
Ling Xin, Xiaogang Xu, Qingyu Shi, et al.
Antimicrobial Agents and Chemotherapy
|
January 9, 2019
Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the <i>In Vitro</i> Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of <i>Enterobacteriaceae</i> and <i>Pseudomonas aeruginosa</i>
Dandan Yin, Shi Wu, Yang Yang, et al.
Infection and Drug Resistance
|
February 27, 2020
Molecular Characteristics and Antimicrobial Susceptibility Profiles of <i>Elizabethkingia</i> Clinical Isolates in Shanghai, China
Leilei Wang, Xuefei Zhang, Dan Li, et al.
Page
of 20
Search research articles
Search
Showing results (61-70 of 192) with videos related to
Sort By:
Page
of 20
Microbial Drug Resistance (Larchmont, N.Y.)
|
September 26, 2019
Study of <i>In Vitro</i> Synergistic Bactericidal Activity of Dual β-Lactam Antibiotics Against KPC-2-Producing <i>Klebsiella pneumoniae</i>
Wenxia Zhang, Yan Guo, Yang Yang, et al.
Antimicrobial Agents and Chemotherapy
|
February 16, 2011
High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum beta-lactamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China
Shudan Chen, Fupin Hu, Xiaogang Xu, et al.
The Journal of Antimicrobial Chemotherapy
|
August 13, 2018
Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae
Jiachun Su, Qinglan Guo, Ying Li, et al.
Plos One
|
April 18, 2013
Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and intestinal commensal Escherichia coli strains
Xiaohua Qin, Fupin Hu, Shi Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 14, 2018
A Case-Control Study: Clinical Characteristics of Nosocomial Bloodstream Infections Versus Non-bloodstream Infections of Acinetobacter spp
Su Xu, Ying Li, Xiaogang Xu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 14, 2025
Emergence of ceftazidime-avibactam resistance in clinical Klebsiella pneumoniae during therapy
Siquan Shen, Xiren Deng, Lu Guo, et al.
International Journal of Antimicrobial Agents
|
June 1, 2024
Dynamic evolution of ceftazidime-avibactam resistance from a single patient through the IncX3_NDM-5 plasmid transfer and bla<sub>KPC</sub> mutation
Chengkang Tang, Siquan Shen, Weiwei Yang, et al.
Frontiers in Microbiology
|
July 25, 2022
High Prevalence and Overexpression of Fosfomycin-Resistant Gene <i>fos</i>X in <i>Enterococcus faecium</i> From China
Ling Xin, Xiaogang Xu, Qingyu Shi, et al.
Antimicrobial Agents and Chemotherapy
|
January 9, 2019
Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the <i>In Vitro</i> Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of <i>Enterobacteriaceae</i> and <i>Pseudomonas aeruginosa</i>
Dandan Yin, Shi Wu, Yang Yang, et al.
Infection and Drug Resistance
|
February 27, 2020
Molecular Characteristics and Antimicrobial Susceptibility Profiles of <i>Elizabethkingia</i> Clinical Isolates in Shanghai, China
Leilei Wang, Xuefei Zhang, Dan Li, et al.
Page
of 20